[Intravesical mitomycin for superficial tumors of the bladder: difficulties of cystoscopic monitoring].
A short series of intravesical prophylactic instillations of mitomycin C for relapsing or multiple superficial bladder tumors is reported. With a mean follow-up of 15 months, 6 out of 9 patients, had abnormal control cystoscopies at 12 months. However, only 2 of these 6 patients have presented with tumor recurrence.
Fourcade
R O
RO
Service de Chirurgie, Urologique, Centre Hospitalier, Auxerre.
Giuliano
F
F
D000283:Administration, Intravesical; D002404:Catheterization; D003558:Cystoscopy; D005500:Follow-Up Studies; D006801:Humans; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000473:pathology; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014546:Urinary Catheterization
D008937:Mitomycins; D016685:Mitomycin
Mitomycine intravésicale pour les tumeurs superficielles de vessie: difficultés de la surveillance cystoscopique.